Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.
- NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_assertion description "[Recipient MTHFR polymorphisms (C677T) were associated with acute GvHD (P=0.03), and recipient VDR TaqI with TRM and overall survival (P=0.006 and P=0.04, respectively).Genetic factors that interfere with drug metabolisms are associated with treatment-related toxicities, GvHD and survival after HLA-identical HSCT in patients with leukemia and should be investigated prospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.
- NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_assertion evidence source_evidence_literature NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.
- NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_assertion SIO_000772 19005482 NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.
- NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_assertion wasDerivedFrom befree-20140225 NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.
- NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_assertion wasGeneratedBy ECO_0000203 NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP242776.RAla6jyhXcUMNA11l4_8ENJmgD9KVraA017odUHY0nzEc130_provenance.